Machine Learning Classification Models to Improve the Docking‐based Screening: A Case of PI3K‐Tankyrase Inhibitors
暂无分享,去创建一个
Vladimir A Palyulin | Vladimir P Berishvili | Andrew E Voronkov | Eugene V Radchenko | A. E. Voronkov | E. Radchenko | V. Berishvili | V. Palyulin
[1] Huikun Zhang,et al. Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening , 2017, J. Chem. Inf. Model..
[2] Lin-Li Li,et al. TS‐Chemscore, a Target‐Specific Scoring Function, Significantly Improves the Performance of Scoring in Virtual Screening , 2015, Chemical biology & drug design.
[3] Christoph A. Sotriffer,et al. SFCscoreRF: A Random Forest-Based Scoring Function for Improved Affinity Prediction of Protein-Ligand Complexes , 2013, J. Chem. Inf. Model..
[4] Kai-Cheng Hsu,et al. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach , 2017, Scientific Reports.
[5] W. Yung,et al. MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma , 2016, Molecular Cancer Therapeutics.
[6] George Papadatos,et al. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.
[7] Ashutosh Kumar,et al. A cross docking pipeline for improving pose prediction and virtual screening performance , 2017, Journal of Computer-Aided Molecular Design.
[8] J. Skolnick,et al. Comprehensive prediction of drug-protein interactions and side effects for the human proteome , 2015, Scientific Reports.
[9] Yu Wang,et al. A comparative study of family-specific protein–ligand complex affinity prediction based on random forest approach , 2015, Journal of Computer-Aided Molecular Design.
[10] Max Kuhn,et al. Building Predictive Models in R Using the caret Package , 2008 .
[11] Gustavo Henrique Goulart Trossini,et al. Use of machine learning approaches for novel drug discovery , 2016, Expert opinion on drug discovery.
[12] S. Krauss,et al. TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer , 2017, Molecular Cancer Research.
[13] Weilin Zhang,et al. Computational Multitarget Drug Design , 2017, J. Chem. Inf. Model..
[14] A. Cleton-Jansen,et al. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. , 2018, Cancer letters.
[15] David Ryan Koes,et al. Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise , 2013, J. Chem. Inf. Model..
[16] Patrick Aloy,et al. Structural systems pharmacology: the role of 3D structures in next-generation drug development. , 2013, Chemistry & biology.
[17] Alexander Tropsha,et al. Target-Specific Native/Decoy Pose Classifier Improves the Accuracy of Ligand Ranking in the CSAR 2013 Benchmark , 2015, J. Chem. Inf. Model..
[18] Rodrigo Dienstmann,et al. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer , 2015, Clinical Cancer Research.
[19] Esben J. Bjerrum,et al. Machine learning optimization of cross docking accuracy , 2016, Comput. Biol. Chem..
[20] S. Chiou,et al. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers , 2015, Oncotarget.
[21] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[22] Jie Liu,et al. Classification of Current Scoring Functions , 2015, J. Chem. Inf. Model..
[23] Sourav Das,et al. Binding Affinity Prediction with Property-Encoded Shape Distribution Signatures , 2010, J. Chem. Inf. Model..
[24] Rodrigo Quiroga,et al. Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening , 2016, PloS one.
[25] Laura Bonati,et al. Modeling Binding with Large Conformational Changes: Key Points in Ensemble-Docking Approaches , 2017, J. Chem. Inf. Model..
[26] Robert P. Sheridan,et al. Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction , 2013, J. Chem. Inf. Model..
[27] Hao Jiang,et al. Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family. , 2017, Journal of medicinal chemistry.
[28] M. Katoh,et al. Molecular genetics and targeted therapy of WNT-related human diseases (Review) , 2017, International journal of molecular medicine.
[29] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[30] Jacob D. Durrant,et al. NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein−Ligand Complexes , 2010, J. Chem. Inf. Model..
[31] Darren Vs Green,et al. Virtual screening of chemical libraries for drug discovery , 2008, Expert opinion on drug discovery.
[32] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[33] Jean Y. J. Wang,et al. Exploiting the promiscuity of imatinib , 2009, Journal of biology.
[34] David Ryan Koes,et al. Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.
[35] Cheng Wang,et al. Improving scoring‐docking‐screening powers of protein–ligand scoring functions using random forest , 2017, J. Comput. Chem..
[36] Cícero Nogueira dos Santos,et al. Boosting Docking-Based Virtual Screening with Deep Learning , 2016, J. Chem. Inf. Model..
[37] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[38] K. Y. Tsang,et al. Synthesis and biological evaluation of sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474. , 2017, Bioorganic & medicinal chemistry.
[39] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[40] C. Porta,et al. Targeting PI3K/Akt/mTOR Signaling in Cancer , 2014, Front. Oncol..
[41] Miao Yu,et al. Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening , 2018, Journal of Computer-Aided Molecular Design.
[42] M L Bolognesi,et al. Polypharmacology in a single drug: multitarget drugs. , 2013, Current medicinal chemistry.
[43] Pedro J. Ballester,et al. Performance of machine-learning scoring functions in structure-based virtual screening , 2017, Scientific Reports.
[44] J B Brown,et al. Classifiers and their Metrics Quantified , 2018, Molecular informatics.
[45] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[46] W. Weis,et al. The β-catenin destruction complex. , 2013, Cold Spring Harbor perspectives in biology.
[47] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..